| Jul 23 |
3 Russell 2000 Growth Stocks That Could Be Worth the Risk
|
| Jul 22 |
Avidity Biosciences Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
|
| Jul 3 |
Avidity’s FSHD drug del-brax shows promise in Phase I/II trial
|
| Jun 20 |
(RNA) - Analyzing Avidity Biosciences's Short Interest
|
| Jun 20 |
Avidity Biosciences Partners with the FSHD Society to Raise Awareness of Facioscapulohumeral Muscular Dystrophy on World FSHD Day
|
| Jun 19 |
Estimating The Intrinsic Value Of Avidity Biosciences, Inc. (NASDAQ:RNA)
|
| Jun 17 |
Avidity Biosciences, Inc. Announces Closing of Upsized Public Offering of Common Stock, Including Full Exercise of Underwriters' Option to Purchase Additional Shares
|
| Jun 16 |
Avidity Biosciences And CleanSpark Were Among The 10 Biggest Mid-Cap Stock Gainers Last Week (June 9-June 15): Are These In Your Portfolio?
|
| Jun 14 |
Avidity Biosciences: Muscular Dystrophy Breakthrough Propels To A 'Buy' Upgrade
|
| Jun 14 |
Avidity Biosciences to Participate in Upcoming Investor Conference
|
